Liver Metastasis Completed Phase Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01834014Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesTreatment